Clinical trial
Evaluation of Lipid Lowering Agents on Diabetic Retinopathy and Cardiovascular Risk of Diabetic Patients
NCT04140201 is registered in ClinicalTrials.gov with Alaa Hassan ElBaz as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Lipid Lowering Agents on Diabetic Retinopathy and Cardiovascular Risk of Diabetic Patients
- Lead sponsor
- Alaa Hassan ElBaz
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- February 29, 2020
- Completion date
- August 31, 2020
- Enrollment
- 80 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.